Welcome to the URCC NCORP Research Base Website
URCC Abstracts for the 2016 ASCO Annual Meeting PDF Print E-mail
Written by Gary Morton   
Friday, 06 May 2016 12:01

URCC Abstracts featured at the 2016 ASCO Annual Meeting (June 3 – June 7, 2016 - McCormick Place Convention Center, Chicago, Illinois

Last Updated on Wednesday, 07 September 2016 10:30
URCC14040 First NCORP IRB Approval PDF Print E-mail
Written by Sebastien Estaque   
Friday, 04 March 2016 15:27

Congratulations to Dayton NCORP, first site to receive IRB approval for URCC14040!


Last Updated on Wednesday, 16 March 2016 12:15
URCC12107 closing to accrual on March 18, 2016 PDF Print E-mail
Written by Sebastien Estaque   
Friday, 04 March 2016 12:05

Due to the current accelerated rate of accrual, we need to move the date that the study is closing to accrual to Friday, March 18, 2016.  

We are changing the date so that we do not exceed our target accrual by a large number.  You will be able to register subjects up until 5:00 PM EST on March 18.  No registrations will be accepted after that time.The study will remain
open and you will be responsible for following all registered subjects at your site until they complete study

Last Updated on Wednesday, 20 April 2016 10:20
URCC 14040 is pre-activated as of 11/16/15 PDF Print E-mail
Tuesday, 17 November 2015 08:36

NCORP Investigators and Staff, As of today 11/16/15, the status of URCC14040 is pre-activated.
To access the documents you must first log in, then click on 14040 YOCAS II under “Active Protocols". Under Regulatory
Documents and Forms; download the 4 documents there (protocol, screening consent form, consent form, study files,
and CRFs). In addition to IRB approval, there are other required steps to be completed prior to activating this protocol at
your site, including coordinator training, identifying and vetting instructors for each of the 3 intervention groups. Please
review the protocol for further details. The NCT number is still pending. Your NCORP will receive 1.0 cancer control
credits/patient accrued to this study.

Last Updated on Tuesday, 17 November 2015 14:18
URCC13059 GAP70+ Amendment 2 Approved PDF Print E-mail
Written by Sebastien Estaque   
Tuesday, 16 February 2016 15:00

URCC13059 GAP70+ Amendment 2 has been approved and is now available on the protocol page.
Please download the regulatory documents and submit to your IRBs. The forms packets will be available within
the next few days.

There will be GAP AMD2 webinars scheduled to review the changes to the protocol and measures. These presentations
will also be posted on our website. 
The first of these webinars will be Thursday, Feb 18, 4-5 PM, EST.

Last Updated on Thursday, 03 March 2016 15:34
URCC12048 closing to accrual on December 31, 2015 PDF Print E-mail
Thursday, 12 November 2015 11:50
Currently 68 of the targeted 70 participants have been accrued to the study.  This protocol was a limited access study
that tarted with only 5 CCOPs participating, then dropping to 4 NCORPs when the Community Oncology program
transitioned. We appreciate everyone’s efforts, especially those of Metro Minnesota who entered 52 of the 68 patients! 
Please forward this information to any investigators and staff at your NCORP who are involved in this study.
Last Updated on Tuesday, 17 November 2015 14:14
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 3 of 10